agilon health (NYSE:AGL) Upgraded at Citigroup
Citigroup upgraded shares of agilon health (NYSE:AGL – Free Report) from a neutral rating to a buy rating in a research report released on Friday, MarketBeat Ratings reports. Citigroup currently has $5.00 price target on the stock, up from their previous price target of $3.25. Several other research firms also recently weighed in on AGL. […]
